Clover Health Investments Corp (CLOV) - Net Assets
Based on the latest financial reports, Clover Health Investments Corp (CLOV) has net assets worth $308.70 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($541.01 Million) and total liabilities ($232.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Clover Health Investments Corp to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $308.70 Million |
| % of Total Assets | 57.06% |
| Annual Growth Rate | N/A |
| 5-Year Change | -42.76% |
| 10-Year Change | N/A |
| Growth Volatility | 19.41 |
Clover Health Investments Corp - Net Assets Trend (2018–2025)
This chart illustrates how Clover Health Investments Corp's net assets have evolved over time, based on quarterly financial data. Also explore CLOV asset base for the complete picture of this company's asset base.
Annual Net Assets for Clover Health Investments Corp (2018–2025)
The table below shows the annual net assets of Clover Health Investments Corp from 2018 to 2025. For live valuation and market cap data, see market value of Clover Health Investments Corp.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $308.70 Million | -9.51% |
| 2024-12-31 | $341.14 Million | +19.12% |
| 2023-12-31 | $286.39 Million | -19.75% |
| 2022-12-31 | $356.89 Million | -33.83% |
| 2021-12-31 | $539.32 Million | +187.95% |
| 2020-12-31 | $-613.19 Million | -3477825.25% |
| 2019-12-31 | $-17.63K | +99.97% |
| 2018-12-31 | $-54.83 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Clover Health Investments Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 176045600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $52.00K | 0.02% |
| Other Comprehensive Income | $528.00K | 0.17% |
| Other Components | $2.60 Billion | 841.09% |
| Total Equity | $308.70 Million | 100.00% |
Clover Health Investments Corp Competitors by Market Cap
The table below lists competitors of Clover Health Investments Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lenzing Aktiengesellschaft
VI:LNZ
|
$1.00 Billion |
|
Valeura Energy Inc
TO:VLE
|
$1.00 Billion |
|
Huangshan Novel Co Ltd
SHE:002014
|
$1.00 Billion |
|
Ningxia Western Venture Industrial Co Ltd
SHE:000557
|
$1.00 Billion |
|
GRIPM Advanced Materials Co. Ltd. A
SHG:688456
|
$1.00 Billion |
|
NorthWest Healthcare Properties Real Estate Investment Trust
TO:NWH-UN
|
$1.00 Billion |
|
Changyuan Group Ltd
SHG:600525
|
$1.00 Billion |
|
PLAYTIKA HOLDING DL-01
F:8II
|
$1.00 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Clover Health Investments Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 341,143,000 to 308,704,000, a change of -32,439,000 (-9.5%).
- Net loss of 85,549,000 reduced equity.
- Share repurchases of 55,198,000 reduced equity.
- New share issuances of 1,814,000 increased equity.
- Other comprehensive income increased equity by 2,112,000.
- Other factors increased equity by 104,382,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-85.55 Million | -27.71% |
| Share Repurchases | $55.20 Million | -17.88% |
| Share Issuances | $1.81 Million | +0.59% |
| Other Comprehensive Income | $2.11 Million | +0.68% |
| Other Changes | $104.38 Million | +33.81% |
| Total Change | $- | -9.51% |
Book Value vs Market Value Analysis
This analysis compares Clover Health Investments Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.54x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-1.31 | $2.71 | x |
| 2019-12-31 | $0.00 | $2.71 | x |
| 2020-12-31 | $-1.53 | $2.71 | x |
| 2021-12-31 | $1.14 | $2.71 | x |
| 2022-12-31 | $0.75 | $2.71 | x |
| 2023-12-31 | $0.59 | $2.71 | x |
| 2024-12-31 | $0.70 | $2.71 | x |
| 2025-12-31 | $0.60 | $2.71 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Clover Health Investments Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -27.71%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.45%
- • Asset Turnover: 3.56x
- • Equity Multiplier: 1.75x
- Recent ROE (-27.71%) is above the historical average (-39.97%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -71.85% | 1.33x | 0.00x | $-196.45 Million |
| 2019 | 0.00% | -78.69% | 4606.72x | 0.00x | $-363.74 Million |
| 2020 | 0.00% | -20.27% | 2.52x | 0.00x | $-74.68 Million |
| 2021 | -109.78% | -39.93% | 1.55x | 1.78x | $-641.30 Million |
| 2022 | -95.15% | -30.97% | 1.36x | 2.27x | $-375.26 Million |
| 2023 | -74.50% | -16.93% | 2.21x | 1.99x | $-242.00 Million |
| 2024 | -12.61% | -3.14% | 2.36x | 1.70x | $-77.12 Million |
| 2025 | -27.71% | -4.45% | 3.56x | 1.75x | $-116.42 Million |
Industry Comparison
This section compares Clover Health Investments Corp's net assets metrics with peer companies in the Healthcare Plans industry.
Industry Context
- Industry: Healthcare Plans
- Average net assets among peers: $9,540,546,667
- Average return on equity (ROE) among peers: -54.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Clover Health Investments Corp (CLOV) | $308.70 Million | 0.00% | 0.75x | $1.00 Billion |
| Alignment Healthcare LLC (ALHC) | $30.61 Million | -74.89% | 10.06x | $3.77 Billion |
| Cigna Corp (CI) | $4.52 Billion | 13.99% | 19.13x | $74.53 Billion |
| Centene Corp (CNC) | $64.09 Million | 20.12% | 1.05x | $19.48 Billion |
| CVS Health Corp (CVS) | $37.96 Billion | 12.23% | 0.95x | $101.04 Billion |
| Elevance Health Inc (ELV) | $24.58 Billion | 12.59% | 1.11x | $63.54 Billion |
| Humana Inc (HUM) | $17.37 Billion | 7.04% | 0.15x | $22.79 Billion |
| Molina Healthcare Inc (MOH) | $64.76 Million | 46.52% | 1.31x | $6.97 Billion |
| Marpai Inc (MRAI) | $6.13 Million | -431.51% | 7.14x | $6.21 Million |
| NeueHealth Inc (NEUE) | $1.27 Billion | -93.04% | 1.83x | $60.94 Million |
About Clover Health Investments Corp
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Del… Read more